Article · 4 May 2026
ArticlePublished 24 Aug 2024
Integrating Bioinformatics and Experimental Data Validating Potential Mechanism of Astragalus Regulating Neurotransmitter Metabolism in Parkinson's Disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This study aims to explore the potential mechanisms of Astragalus membranaceus in the treatment of Parkinson's disease with a particular focus on its role in neurotransmitter regulation. Firstly, using network pharmacology methods, we screened potential active ingredients from Astragalus membranaceus based on Traditional Chinese Medicine Systems Pharmacology Database criteria, with oral bioavailability≥40 % and drug-likeness≥0.1. Subsequently, potential protein targets of these active ingredients were predicted using databases such as SwissTargetPrediction and Search Tool for Interacting Chemicals. Targets related to Parkinson's disease and dopamine metabolism were obtained from GeneCards and Online Mendelian Inheritance in Man databases. We then constructed networks of active ingredients and targets, further filtering out targets associated with Parkinson's disease. Lastly, a protein-protein interaction network was constructed using the Search Tool for the Retrieval of Interacting Genes/Proteins database and key genes in the network were quantified using the MCODE application. Functional enrichment analysis was performed using Gene Ontology/Kyoto Encyclopedia of Genes and Genomes. Finally, molecular docking was employed to validate target genes. Our findings identified the muscarinic cholinergic receptor 2 gene as one of the potential targets of Astragalus membranaceus in treating Parkinson's disease. Further bioinformatics analysis revealed the modulatory effect of Astragalus membranaceus on the acetylcholine receptor signaling pathway, providing new theoretical insights into its neuroprotective effect. This study, employing a comprehensive approach of network pharmacology and bioinformatics analysis, elucidated the potential mechanisms of Astragalus membranaceus in Parkinson's disease treatment, emphasizing the significant role of neurotransmitter regulation.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hongwei Zhang”
- BylineArticles whose byline prints “Jiantang Wang”
- BylineArticles whose byline prints “Fu Yuan”
- BylineArticles whose byline prints “Yukun Zhang”